Why Hexo (TSX:HEXO) Stock Will Likely Double Again in 2021

Hexo stock could shoot much higher this year if things fall into place for this small regional player. Here’s why I think the timing might be right to pick up shares of this company before they go parabolic.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

In the Canadian cannabis sector, one of my top picks for some time has been Hexo (TSX:HEXO)(NYSE:HEXO). My conviction level on this cannabis player relative to its peers hasn’t shifted of late.

I think Hexo is a stock that has had a rough go of it in 2020 but is turning things around in the right direction. I think this stock has the potential to double from current levels to around the $20 level before the year is done. Here’s why.

Domestic market performance likely to be the story with this stock

Unlike peers I’ve written about late that have significant U.S. exposure, Hexo is a Canada-focused cannabis firm. I think most of the upside is within regional markets in Canada. This is a company which is the market leader for cannabis sales in Quebec — something I don’t expect to change. Hexo has a very lucrative contract with the Quebec government. Indeed, as we’ve seen with other industries, Quebec is very isolationist with respect to its supply chain. The Quebec government is also very supportive of its local businesses. With the Quebec market likely to grow to one of the largest in Canada, this is very bullish for Hexo investors.

There may be room for Hexo to grow in the U.S., though I don’t see this as a likely scenario to play out. I think as long as this company stays right-sized and focuses on its core business, it will do fine.

Capital needs look to be covered

As fellow Fool contributor Brian Paradza wrote in a recent piece, Hexo looks to be on track to have its capital needs covered from here on out. He wrote: “The company once flirted with the possibility of bankruptcy at one point. Lenders gave management a deadline by which to raise new equity. The stock price was in free fall, and there was no guarantee that the markets will continue to fund the firm. Fortunately, funding was secured just in time. Management doesn’t see a need for new and dilutive equity financing anymore. At least not in the near term. The executive team is positive on the firm’s balance sheet and cash flow outlook.”

I think Paradza is right on the money here. As long as Hexo is able to execute its domestic strategy and doesn’t go crazy with acquisitions, this is a nice niche player that could outperform in the domestic Canadian cannabis market. Hexo looks to have a long-term capital funding plan in place. Concerns about the potential for bankruptcy appear to be in the rear-view mirror. Accordingly, I see a lot of upside for this stock if Hexo can improve its margins and show a path to profitability in 2021.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »